Site maintenance Wednesday, November 13th, 2024. Please note that access to some content and account information will be unavailable on this date.
Skip to main content
Full access
Brief Reports
Published Online: 1 September 2014

Service Users’ Priorities and Preferences for Treatment of Psychosis: A User-Led Delphi Study

Abstract

Objective

Service users may have different priorities and preferences for treatment compared with mental health professionals. Few studies have explored these potentially important differences. This study sought consensus from a sample of service users regarding priorities and preferences for treatment of psychosis.

Methods

A three-stage Delphi study exploring treatment priorities and preferences was conducted with a sample of mental health service users (“experts by experience”). After generation of an initial statement list (stage 1, N=6 participants), 64 diverse elements of mental health treatment were rated during a two-stage online survey process (stage 2, N=32; stage 3, N=21).

Results

Fifteen of 64 treatment-related statements were endorsed as important or essential treatment priorities or preferences by more than 80% of participants during stage 2. Two further statements were similarly endorsed during stage 3.

Conclusions

This study is among the first of its kind and highlights the importance of assessing individual treatment priorities.
Recent U.K. government initiatives affirm that the perspectives and preferences of service users should play an important part in mental health decision making (1,2). However, people seeking help for psychosis- or schizophrenia-associated difficulties may find that their personal priorities and preferences differ from those of clinicians or that these factors are not adequately considered (3).
Clinicians and researchers in this field have primarily focused on the positive symptoms of psychosis (such as hearing voices or experiencing paranoia), and antipsychotic medication is often the only active treatment offered (4). Although antipsychotic medication is helpful for some, it is ineffective for others and is associated with significant adverse effects that may outweigh perceived benefits and lead to discontinuation (5,6). It has been suggested that there is an excessive reliance on antipsychotic medication in the treatment of schizophrenia and related disorders and that there is “little or no choice offered to service users who meet criteria for such diagnoses, despite policies that actively promote patient-led care, collaborative decision-making and provision of choice” (7).
Although there is a need, therefore, to consider service users’ priorities and choice of treatment, research assessing these factors is limited. A number of studies have compared the priorities of service users, caregivers, and mental health professionals (8,9) and have reported differences between these groups. Differences between individual service users have also been found in ratings of treatment priorities and preferences (10), although the most recent research in this area suggests it may be possible to identify areas of consensus among a large group of service users (11).
Several studies have used the Delphi method to seek expert consensus regarding treatment for psychosis or schizophrenia (12,13). However, such studies tend to include only professional participants, such as psychiatrists or psychologists, who may not prioritize elements of treatment that are important from a service user perspective. This study aimed to address this potential source of research bias by conducting a user-led Delphi method evaluation of user-defined treatment outcome priorities and treatment preferences.

Methods

Delphi method studies are consensus-seeking surveys of expert opinion, often conducted in three stages (12). We sought to recruit a sample of individuals with experience of receiving treatment for psychosis or schizophrenia (“experts by experience”) to complete a Delphi method survey examining treatment priorities and preferences. Appropriate ethical approvals were obtained from local university and National Health Service research ethics committees. During the first stage of the study, a literature search was conducted to identify treatment factors of potential importance to service users. Relevant research surveyed included quantitative studies of service users’ treatment priorities and preferences and qualitative studies of service users’ experiences of treatment and recovery. A diverse range of treatment factors was identified and listed until thematic sufficiency was achieved (that is, until no new items were identified).
These items (N=77) were listed in a numbered series of statements (for example, “It is most important for me to get help with depression”) alongside a Likert rating scale (1, essential, to 5, not required). This statement list was then sent to members of a local Service User Reference Group for consultation (N=6), each with experience of treatment for psychosis or schizophrenia. After group rating and discussion, 13 items were removed from the statement list, and a final statement list comprising 64 items was organized into four sections: current treatment priorities, long-term priorities, treatment preferences, and additional treatment preferences.
The second and third stages of the study were conducted online between January and August, 2012, and recruitment was achieved with the help of the Rethink Mental Illness charity, which advertised the study through e-mail and online social networks (for example, Facebook and Twitter). Online study material consisted of a participant information sheet and a consent form, along with the four-part statement list and accompanying Likert rating scale. Before they could progress to the survey section, participants were required to complete the consent form (online “tickbox” format) and were asked to provide an e-mail address to which we could send the next stage of the survey. All participants completed the online consent form. Among the 32 stage 2 participants, 50% were female and 59% were between the ages of 20 and 39. Among the 21 stage 3 participants, 45% were female and 55% were between the ages of 20 and 39. Race-ethnicity was not recorded for this study. [A table with more data on participant characteristics is included in an online data supplement to this report.]
At the prespecified end date for completion of stage 2 of the study, responses were analyzed by calculating percentages for the group (N=32 participants). Statements rated as essential or important by at least 80% of participants were included in a final statement list. Statements rated as essential or important by between 70% and 79% of participants were included in the stage 3 survey for rerating. Statements that did not meet either of these conditions were excluded. Participants were then e-mailed a direct link to the stage 3 survey Web page. The same rating criteria as above were used to analyze stage 3 responses (N=21 participants).

Results

Sixty-four treatment-related statements were generated during stage 1. During stage 2 of the study, 15 of these items were rated essential or important by at least 80% of participants and included in the final statement set. Twelve statements were rated essential or important by 70%−79% of participants and rerated at stage 3, after which two additional statements were included in the final statement set (Table 1). [Tables presenting participants’ ratings for these statements and for statements not included in the final set are included in the online data supplement.]
Table 1 Statements about treatment priorities and preferences endorsed by service users in a Delphi study
StatementStage included
What I most want help with 
 Feeling paranoid2
 Stress2
 Anxiety or feeling nervous2
 Feeling confused or unable to control my thoughts2
 Concentration or memory problems2
What I want for the long term 
 Understand my psychological problems2
 Learn to cope with ongoing “unusual psychological experiences”2
 Improve my emotional well-being2
 Improve my energy and motivation2
 Feel better about myself2
 Improve my concentration and memory2
 Remain out of the hospital (for my mental health issues)3
What I would prefer when I receive mental health help 
 Offer help based on my individual problems (rather than help based on a clinical diagnosis)2
 Inform me about different types of help available2
 Allow me to play a part in making decisions about what kind of help is best for me2
What I prefer when meeting with mental health staff 
 In private (between myself and staff)3
 Offer help that’s appropriate for different age groups2
Strong consensus was noted for particular treatment factors in a number of areas. The most frequently endorsed current treatment priorities included paranoia, stress and anxiety, confusion, and concentration-memory. Long-term priorities included improved understanding (of mental health), coping ability, emotional well-being, and staying out of the hospital. Frequently endorsed treatment preferences included individualized care and collaborative decision making, greater information and treatment choice, privacy (when meeting with mental health staff), and age-appropriate care.

Discussion and conclusions

There are few existing studies with which to compare our findings, and it is difficult to compare these findings directly because methodologies in this topic area vary. Nonetheless it is worth highlighting a number of general similarities. Rosenheck and colleagues (10) reported that among a large sample (N=1,200) of individuals with schizophrenia diagnoses, the most common treatment priority was reducing confusion, which is echoed in this study and in a number of studies in this area (11,14). Fischer and colleagues (8) found that service users and their family members more often prioritized social support, housing, and medical services, compared with service providers. Shumway and colleagues (9) found that across groups of service providers, users, policy makers, and family members, participants valued social and functional improvements more than reductions in psychotic symptoms. Although our participants prioritized social and functional improvements less clearly, they prioritized treatment of psychotic symptoms less frequently than more general psychological and emotional improvements (such as reduced confusion and stress and improved understanding).
The clearest limitation of this study was our small sample, because analysis of data drawn from a larger sample may have enabled identification of differences between groups of participants. In addition, online social network–based recruitment may have excluded some potential participants. People with psychosis or schizophrenia may be economically disadvantaged (15) and may not have private access to the Internet, whereas older people may be less likely to access social networking media in general. It is also possible that some people in our target population may not have been comfortable participating in this kind of study over the Internet. The option to request paper copies of study materials was offered in our advertising information to reduce the risk of excluding potential participants, but none were requested. The validity of our results is also limited by the inclusion of several participants who identified as having primary diagnoses other than psychosis or schizophrenia (for example, bipolar disorder). Control of inclusion was limited by the open-access nature of our recruitment strategy. This could be addressed in similar studies conducted online with more effectively targeted recruitment strategies. It may also have been desirable to collect more detailed information about participants’ current difficulties and self-defined recovery status, because treatment priorities may change over time.
Our results identified a number of commonly valued treatment priorities, suggesting these as important areas for clinical attention (for example, confusion, anxiety, and stress). The most highly valued treatment preferences we identified reflect a desire for more information, choice, and collaboration in treatment decision making, suggesting that participants are not routinely satisfied in these areas. It is also worth noting that among the survey items most frequently endorsed as unnecessary, the use of medical terminology and attending appointments at mental health service premises were identified, suggesting that some aspects of routine psychiatric care may not be considered helpful by service users.
The relatively low levels of group consensus for many elements of treatment reinforce the need to evaluate the individual’s personal priorities in clinical practice. It is reasonable to suggest that greater concordance between an individual’s priorities and preferences and the treatment that he or she is offered will enhance continued engagement. As Bailey and colleagues (6) suggested in a recent article addressing the risks of general medical illness among people with serious mental health problems, especially those prescribed antipsychotic medication, “it is perhaps now worth reflecting on what might most trouble the young person facing you in the consulting room—the weight gain or the reduction in mental health symptoms.”

Acknowledgments and disclosures

The authors thank the U.K. Rethink Mental Illness charity for help with online recruitment for the study.
The authors report no competing interests.

Supplementary Material

Supplemental Material (1167_ds001.pdf)

References

1.
National Service Framework for Mental Health: Modern Standards and Service Models. London, Department of Health, 1999
2.
Psychosis and Schizophrenia in Adults: Treatment and Management. London, National Institute for Clinical Excellence, 2014
3.
Greenwood KE, Sweeney A, Williams S, et al.: CHoice of Outcome In Cbt for psychosEs (CHOICE): the development of a new service user-led outcome measure of CBT for psychosis. Schizophrenia Bulletin 36:126–135, 2010
4.
Warner L, Mariathasan J, Lawton-Smith S, et al: A Review of the Literature and Consultation on Choice and Decision-Making for Users and Carers of Mental Health and Social Care Services. London, Sainsbury Centre for Mental Health, 2006
5.
Lieberman JA, Stroup TS, McEvoy JP, et al.: Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine 353:1209–1223, 2005
6.
Bailey S, Gerada C, Lester H, et al.: The cardiovascular health of young people with severe mental illness: addressing an epidemic within an epidemic. Psychiatrist 36:375–378, 2012
7.
Morrison AP, Hutton P, Shiers D, et al.: Antipsychotics: is it time to introduce patient choice? British Journal of Psychiatry 201:83–84, 2012
8.
Fischer EP, Shumway M, Owen RR: Priorities of consumers, providers, and family members in the treatment of schizophrenia. Psychiatric Services 53:724–729, 2002
9.
Shumway M, Saunders T, Shern D, et al.: Preferences for schizophrenia treatment outcomes among public policy makers, consumers, families, and providers. Psychiatric Services 54:1124–1128, 2003
10.
Rosenheck R, Stroup S, Keefe RS, et al.: Measuring outcome priorities and preferences in people with schizophrenia. British Journal of Psychiatry 187:529–536, 2005
11.
Sterk B, Winter van Rossum I, Muis M, et al.: Priorities, satisfaction and treatment goals in psychosis patients: an online consumer’s survey. Pharmacopsychiatry 46:88–93, 2013
12.
Langlands RL, Jorm AF, Kelly CM, et al.: First aid recommendations for psychosis: using the Delphi method to gain consensus between mental health consumers, carers, and clinicians. Schizophrenia Bulletin 34:435–443, 2008
13.
Morrison AP, Barratt S: What are the components of CBT for psychosis? A Delphi study. Schizophrenia Bulletin 36:136–142, 2010
14.
de Haan L, van Raaij B, van den Berg R, et al.: Preferences for treatment during a first psychotic episode. European Psychiatry 16:83–89, 2001
15.
Lester H, Marshall M, Jones P, et al.: Views of young people in early intervention services for first-episode psychosis in England. Psychiatric Services 62:882–887, 2011

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services

Cover: Girl on a Swing, by Maxfield Parrish. Drawing, oil on paper. The Metropolitan Museum of Art, bequest of Susan Vanderpoel Clark (67.155.3). Image © Metropolitan Museum of Art, New York. Image source: Art Resource. New York.

Psychiatric Services
Pages: 1167 - 1169
PubMed: 24933125

History

Published online: 1 September 2014
Published in print: September 2014

Authors

Details

Rory Byrne, B.Sc.
The authors are with the Department of Psychology, Greater Manchester West Mental Health National Health Service Foundation Trust, Prestwich, Manchester, United Kingdom (e-mail: [email protected]).
Anthony P. Morrison, Clin.Sci.D.
The authors are with the Department of Psychology, Greater Manchester West Mental Health National Health Service Foundation Trust, Prestwich, Manchester, United Kingdom (e-mail: [email protected]).

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Get Access

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login
Purchase Options

Purchase this article to access the full text.

PPV Articles - Psychiatric Services

PPV Articles - Psychiatric Services

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share